SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950133-01-000619
Filing Date
2001-02-14
Accepted
2001-02-14 00:00:00
Documents
1
Group Members
BB BIOTECH AGBIOTECH TARGET S.A.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT w45368jsc13ga.txt SC 13G/A 10971
  Complete submission text file 0000950133-01-000619.txt   13079
Mailing Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006
Business Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006 2028351882
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: DC | Fiscal Year End: 1231
SIC: 0000

Mailing Address 223 WILMINGTON-WEST CHESTER PIKE CHADDS FORD PA 19317
Business Address 223 WILMINGTON-WEST CHESTER PIKE CHADDS FORD PA 19317 6105589800
ENDO PHARMACEUTICALS HOLDINGS INC (Subject) CIK: 0001100962 (see all company filings)

IRS No.: 134022871 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-59365 | Film No.: 1545087
SIC: 2834 Pharmaceutical Preparations